Home > PE Ratio > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
PE (Price/Earnings) Ratio

The Current P/E Ratio of OXYGENTA PHARMACEUTICAL is -2,212.15.

Share Price ₹78.9Apr 01,2025
Market Cap ₹292.0 Cr
Earnings-TTM₹-0.1 CrTTM-Standalone Results
Price/Earnings-2,212.15xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of OXYGENTA PHARMACEUTICAL

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of OXYGENTA PHARMACEUTICAL is calculated as :

Current Market Cap [ ₹292.0 Cr] as on Apr 01,2025

(/) Earnings [ ₹-0.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ -2,212.15x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay -2,212.15 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of OXYGENTA PHARMACEUTICAL !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of OXYGENTA PHARMACEUTICAL over the last five years.

Historical PE (Price/Earnings) ratio chart of OXYGENTA PHARMACEUTICAL


PE Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL

- OXYGENTA PHARMACEUTICAL 's latest p/e ratio is -2,212.15x.

- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.

- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 0x.

- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does OXYGENTA PHARMACEUTICAL 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
OXYGENTA PHARMACEUTICAL -0.13-2,212.15292.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0035.45407,155.0
DIVIS LABORATORIES LTD2,067.0071.26147,295.0
CIPLA LTD5,000.4323.33116,664.0
TORRENT PHARMACEUTICALS LTD1,862.0057.83107,678.0
DR REDDYS LABORATORIES LTD5,428.6017.7196,162.6
MANKIND PHARMA LTD2,050.7349.43101,358.0
ZYDUS LIFESCIENCES LTD4,591.8019.2388,297.0
LUPIN LTD2,892.1030.8889,322.4
AUROBINDO PHARMA LTD3,500.2518.8365,912.3
ABBOTT INDIA LTD1,334.4648.2664,397.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs OXYGENTA PHARMACEUTICAL 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -2.00x
Max industry PE 71.26x
Median industry PE 30.88x
Average industry PE 33.66x



You may also like the below Video Courses